Literature DB >> 23921246

Fate of the contralateral limb after lower extremity amputation.

Julia D Glaser1, Rodney P Bensley, Rob Hurks, Suzanne Dahlberg, Allen D Hamdan, Mark C Wyers, Elliot L Chaikof, Marc L Schermerhorn.   

Abstract

OBJECTIVE: Lower extremity amputation is often performed in patients where both lower extremities are at risk due to peripheral arterial disease or diabetes, yet the proportion of patients who progress to amputation of their contralateral limb is not well defined. We sought to determine the rate of subsequent amputation on both the ipsilateral and contralateral lower extremities following initial amputation.
METHODS: We conducted a retrospective review of all patients undergoing lower extremity amputation (exclusive of trauma or tumor) at our institution from 1998 to 2010. We used International Classification of Diseases-Ninth Revision codes to identify patients and procedures as well as comorbidities. Outcomes included the proportion of patients at 1 and 5 years undergoing contralateral and ipsilateral major and minor amputation stratified by initial major vs minor amputation. Cox proportional hazards regression analysis was performed to determine predictors of major contralateral amputation.
RESULTS: We identified 1715 patients. Mean age was 67.2 years, 63% were male, 77% were diabetic, and 34% underwent an initial major amputation. After major amputation, 5.7% and 11.5% have a contralateral major amputation at 1 and 5 years, respectively. After minor amputation, 3.2% and 8.4% have a contralateral major amputation at 1 and 5 years while 10.5% and 14.2% have an ipsilateral major amputation at 1 and 5 years, respectively. Cox proportional hazards regression analysis revealed end-stage renal disease (hazard ratio [HR], 3.9; 95% confidence interval [CI], 2.3-6.5), chronic renal insufficiency (HR, 2.2; 95% CI, 1.5-3.3), atherosclerosis without diabetic neuropathy (HR, 2.9; 95% CI, 1.5-5.7), atherosclerosis with diabetic neuropathy (HR, 9.1; 95% CI, 3.7-22.5), and initial major amputation (HR, 1.8; 95% CI, 1.3-2.6) were independently predictive of subsequent contralateral major amputation.
CONCLUSIONS: Rates of contralateral limb amputation are high and predicted by renal disease, atherosclerosis, and atherosclerosis with diabetic neuropathy. Physicians and patients should be alert to the high risk of subsequent amputation in the contralateral leg. All patients, but particularly those at increased risk, should undergo close surveillance and counseling to help prevent subsequent amputations in their contralateral lower extremity.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23921246      PMCID: PMC3844063          DOI: 10.1016/j.jvs.2013.06.055

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  33 in total

Review 1.  Major amputations: clinical patterns and predictors.

Authors:  J Dormandy; L Heeck; S Vig
Journal:  Semin Vasc Surg       Date:  1999-06       Impact factor: 1.000

2.  New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up.

Authors:  E Faglia; F Favales; A Morabito
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

3.  Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia

Authors:  N Unwin
Journal:  Br J Surg       Date:  2000-03       Impact factor: 6.939

4.  Racial differences in the incidence of limb loss secondary to peripheral vascular disease: a population-based study.

Authors:  Timothy R Dillingham; Liliana E Pezzin; Ellen J Mackenzie
Journal:  Arch Phys Med Rehabil       Date:  2002-09       Impact factor: 3.966

5.  Functional outcome in a contemporary series of major lower extremity amputations.

Authors:  Mark R Nehler; Joseph R Coll; William R Hiatt; Judith G Regensteiner; Gabriel T Schnickel; William A Klenke; Pam K Strecker; Michelle W Anderson; Darrell N Jones; Thomas A Whitehill; Shevie Moskowitz; William C Krupski
Journal:  J Vasc Surg       Date:  2003-07       Impact factor: 4.268

6.  Major lower-extremity amputation: contemporary experience in a single Veterans Affairs institution.

Authors:  Boulos Toursarkissian; Paula K Shireman; Amy Harrison; Marcus D'Ayala; John Schoolfield; Mellick T Sykes
Journal:  Am Surg       Date:  2002-07       Impact factor: 0.688

7.  A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases.

Authors:  Frank B Pomposelli; Nikhil Kansal; Alan D Hamdan; Alana Belfield; Malachi Sheahan; David R Campbell; John J Skillman; Frank W Logerfo
Journal:  J Vasc Surg       Date:  2003-02       Impact factor: 4.268

8.  Major lower extremity amputation in an academic vascular center.

Authors:  Ahmed M Abou-Zamzam; Theodore H Teruya; J David Killeen; Jeffrey L Ballard
Journal:  Ann Vasc Surg       Date:  2003-01-15       Impact factor: 1.466

9.  Limb amputation and limb deficiency: epidemiology and recent trends in the United States.

Authors:  Timothy R Dillingham; Liliana E Pezzin; Ellen J MacKenzie
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

10.  Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study.

Authors:  Brian C Callaghan; Eva Feldman; Jennifer Liu; Kevin Kerber; Rodica Pop-Busui; Howard Moffet; Andrew J Karter
Journal:  Diabetes Care       Date:  2011-02-01       Impact factor: 19.112

View more
  9 in total

1.  Rates and timing of subsequent amputation after initial minor amputation.

Authors:  Jonathan H Lin; Sun Young Jeon; Patrick S Romano; Misty D Humphries
Journal:  J Vasc Surg       Date:  2020-01-21       Impact factor: 4.268

Review 2.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

3.  Midterm Fate of the Contralateral Foot in Charcot Arthropathy.

Authors:  Felix W A Waibel; Martin C Berli; Viviane Gratwohl; Kati Sairanen; Dominik Kaiser; Laura Shin; David G Armstrong; Madlaina Schöni
Journal:  Foot Ankle Int       Date:  2020-07-22       Impact factor: 2.827

4.  Risk of contralateral lower limb amputation and death after initial lower limb amputation - a population-based study.

Authors:  K Huseynova; R Sutradhar; G L Booth; A Huang; J G Ray
Journal:  Heliyon       Date:  2018-10-09

5.  Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission.

Authors:  Lawrence A Lavery; Brian J Petersen; David R Linders; Jonathan D Bloom; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2019-08-06

Review 6.  Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.

Authors:  Rongqi Liu; Brian J Petersen; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

Review 7.  Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources.

Authors:  Michael P Dillon; Matthew Quigley; Stefania Fatone
Journal:  Syst Rev       Date:  2017-03-14

8.  Ulcer metastasis? Anatomical locations of recurrence for patients in diabetic foot remission.

Authors:  Brian J Petersen; Gary M Rothenberg; Priti J Lakhani; Min Zhou; David R Linders; Jonathan D Bloom; Katherine A Wood; David G Armstrong
Journal:  J Foot Ankle Res       Date:  2020-01-13       Impact factor: 2.303

9.  Outcomes of Total Knee Arthroplasty with a Prior Contralateral Above-Knee Amputation: A Report of 10 Cases.

Authors:  Timothy G Visser; Mark W Mason
Journal:  Arthroplast Today       Date:  2020-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.